Group Lead, AOC Platform for Extrahepatic Delivery

A*STAR Research; Singapore; On-site; SGD 120,000 - 180,000; Full time

Benefits offered by this job

Attractive benefits

Long-term career growth opportunities

Job summary

A leading biomedical research institute in Singapore seeks a highly innovative Group Leader for Antibody-Oligonucleotide Conjugates. The role involves building and leading a team focused on developing advanced therapeutic modalities. Responsibilities include defining design principles, guiding strategies for antibody discovery, and establishing bioconjugation processes. Candidates should have a doctoral degree and significant experience in the biotech or pharmaceutical fields. This position offers attractive benefits and opportunities for career growth within Singapore's evolving biomedical landscape.

Qualifications

• 8+ years of experience in pharmaceutical or biotech organizations.
• Demonstrated track record in antibody discovery/engineering and bioconjugation.
• Proven ability to lead cross-functional teams efficiently.

Responsibilities

• Define AOC design principles for extrahepatic delivery.
• Guide antigen and epitope strategy for tissue targeting.
• Establish analytical methods to quantify conjugate stability.

Skills

Antibody discovery

Bioconjugation

Linker chemistry

Project management

Interpersonal skills

Education

Doctoral degree in relevant field

Tools

Flow cytometry

LC-MS

SEC

Job description

A leading biomedical research institute in Singapore seeks a highly innovative Group Leader for Antibody-Oligonucleotide Conjugates. The role involves building and leading a team focused on developing advanced therapeutic modalities. Responsibilities include defining design principles, guiding strategies for antibody discovery, and establishing bioconjugation processes. Candidates should have a doctoral degree and significant experience in the biotech or pharmaceutical fields. This position offers attractive benefits and opportunities for career growth within Singapore's evolving biomedical landscape.